Cargando…
A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability
Resveratrol (RES) has a low bioavailability. This limitation was addressed in an earlier review and several recommendations were offered. A literature search was conducted in order to determine the extent of the research that was conducted in line with these recommendations, along with new developme...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305180/ https://www.ncbi.nlm.nih.gov/pubmed/34299642 http://dx.doi.org/10.3390/molecules26144367 |
_version_ | 1783727512547753984 |
---|---|
author | de Vries, Konrad Strydom, Morné Steenkamp, Vanessa |
author_facet | de Vries, Konrad Strydom, Morné Steenkamp, Vanessa |
author_sort | de Vries, Konrad |
collection | PubMed |
description | Resveratrol (RES) has a low bioavailability. This limitation was addressed in an earlier review and several recommendations were offered. A literature search was conducted in order to determine the extent of the research that was conducted in line with these recommendations, along with new developments in this field. Most of the identified studies were pre-clinical and confirmed the heightened activity of RES analogues compared to their parent compound. Although this has provided additional scientific kudos for these compounds and has strengthened their potential to be developed into phytopharmaceutical products, clinical trials designed to confirm this increased activity remain lacking and are warranted. |
format | Online Article Text |
id | pubmed-8305180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83051802021-07-25 A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability de Vries, Konrad Strydom, Morné Steenkamp, Vanessa Molecules Review Resveratrol (RES) has a low bioavailability. This limitation was addressed in an earlier review and several recommendations were offered. A literature search was conducted in order to determine the extent of the research that was conducted in line with these recommendations, along with new developments in this field. Most of the identified studies were pre-clinical and confirmed the heightened activity of RES analogues compared to their parent compound. Although this has provided additional scientific kudos for these compounds and has strengthened their potential to be developed into phytopharmaceutical products, clinical trials designed to confirm this increased activity remain lacking and are warranted. MDPI 2021-07-20 /pmc/articles/PMC8305180/ /pubmed/34299642 http://dx.doi.org/10.3390/molecules26144367 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review de Vries, Konrad Strydom, Morné Steenkamp, Vanessa A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability |
title | A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability |
title_full | A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability |
title_fullStr | A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability |
title_full_unstemmed | A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability |
title_short | A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability |
title_sort | brief updated review of advances to enhance resveratrol’s bioavailability |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305180/ https://www.ncbi.nlm.nih.gov/pubmed/34299642 http://dx.doi.org/10.3390/molecules26144367 |
work_keys_str_mv | AT devrieskonrad abriefupdatedreviewofadvancestoenhanceresveratrolsbioavailability AT strydommorne abriefupdatedreviewofadvancestoenhanceresveratrolsbioavailability AT steenkampvanessa abriefupdatedreviewofadvancestoenhanceresveratrolsbioavailability AT devrieskonrad briefupdatedreviewofadvancestoenhanceresveratrolsbioavailability AT strydommorne briefupdatedreviewofadvancestoenhanceresveratrolsbioavailability AT steenkampvanessa briefupdatedreviewofadvancestoenhanceresveratrolsbioavailability |